Revenue and Profitability Trends
In the fiscal year ending March 2025, Borosil Scienti. reported consolidated net sales of ₹438.49 crores, reflecting a robust increase of approximately 10.7% compared to ₹395.98 crores in the previous year. This growth in top-line revenue was accompanied by a rise in total operating income, which stood at ₹438.49 crores, unchanged from net sales as there was no other operating income reported.
The company managed to contain its expenditure growth, with total expenditure excluding depreciation rising to ₹385.90 crores from ₹349.30 crores the year before. This controlled cost environment helped boost operating profit before depreciation and interest (PBDIT) excluding other income to ₹52.59 crores, up from ₹46.68 crores, indicating an improvement in operational efficiency.
Other income nearly doubled to ₹7.82 crores, contributing to a consolidated operating profit (PBDIT) of ₹60.41 crores, a significant increase from ₹50.70 crores in the prior year. Interest expenses declined notably to ₹1.55 crores from ₹2.70 crores, reflecting better debt management or refinancing benefits.
Consequently, profit before tax rose sharply to ₹40.39 crores from ₹31.55 crores, while profit after tax increased to ₹26.72 crores compared to ₹23.48 crores. The consolidated net profit margin improved marginally to 6.09% from 5.93%, and earnings per share (EPS) rose to ₹3.01 from ₹2.65, signalling enhanced shareholder value.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Balance Sheet and Asset Quality
Borosil Scienti.’s balance sheet as of March 2025 shows a strengthening financial position. Shareholders’ funds increased to ₹404.39 crores from ₹375.90 crores, supported by a rise in reserves to ₹395.49 crores. The company’s total liabilities grew moderately to ₹504.34 crores from ₹488.31 crores, with a notable reduction in long-term borrowings to ₹1.74 crores from ₹4.50 crores, indicating a lower debt burden.
Short-term borrowings remained relatively stable at ₹12.39 crores, while total debt decreased to ₹14.13 crores from ₹16.58 crores. The book value per share improved to ₹45.47 from ₹42.33, reflecting enhanced net asset value per equity share.
On the asset side, total assets rose to ₹504.34 crores from ₹488.31 crores. Current assets increased to ₹309.95 crores, driven by the addition of current investments worth ₹105.42 crores, which were absent in the previous year. Inventories and sundry debtors also saw moderate increases, supporting operational needs. Net current assets improved to ₹222.82 crores from ₹190.57 crores, signalling healthy liquidity.
Capital expenditure activity is evident with gross block rising to ₹280.39 crores from ₹267.07 crores, although accumulated depreciation also increased, resulting in a slight decline in net block to ₹187.47 crores from ₹192.24 crores.
Cash Flow and Financial Health
The company’s cash flow position reflects strong operational cash generation. Cash flow from operating activities surged to ₹120 crores from ₹30 crores, supported by a significant positive change in working capital of ₹72 crores compared to a negative ₹4 crores previously. This improvement indicates better management of receivables, payables, and inventory.
Investing activities saw a substantial outflow of ₹115 crores, likely related to capital expenditure or strategic investments, compared to a minor outflow of ₹2 crores the prior year. Financing activities recorded a modest outflow of ₹3 crores, down from ₹16 crores, suggesting reduced reliance on external funding.
Despite these movements, the net cash inflow was modest at ₹1 crore, with closing cash and cash equivalents rising slightly to ₹13 crores from ₹12 crores, maintaining a stable liquidity buffer.
Borosil Scienti. or something better? Our SwitchER feature analyzes this Smallcap Industrial Products stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary and Outlook
Overall, Borosil Scienti. has exhibited consistent growth in revenue and profitability over the last fiscal year, supported by disciplined cost control and improved operational efficiency. The company’s balance sheet remains robust with reduced debt levels and increased reserves, while cash flow generation has strengthened significantly.
These factors collectively suggest that Borosil Scienti. is well-positioned to sustain its growth trajectory and enhance shareholder returns. Investors may find the company’s improving fundamentals and prudent financial management encouraging as it navigates the competitive industrial products landscape.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
